Thematic investing

Healthy Living

Good health is increasingly recognized as a powerful human and economic asset. Beyond improving the quality of life, it helps individuals remain independent, active, and engaged – enabling sustained vitality throughout all of life’s stages.

  • 12.5

    USD trillion, potential boost in global GDP by 2050 from improved health1

  • 40

    years increase in life expectancy in Asia over the past 100 years, reaching now an average of 75 years2

  • +22%

    increase in employment rate for ages 60-64 across OECD, 2004-20243

The global economy is entering a new era, defined by longer lives and lower birth rates. Health is no longer just about treating illnesses, but increasingly about maximizing wellbeing and extending healthy years, enabling people to contribute to society for longer. By living longer and stronger, individuals can achieve their full potential, driving a more productive workforce, stronger communities and more resilient economic growth. Healthy living is therefore central to solving the demographic dilemma of longevity while unlocking economic opportunities.

Why invest in healthy living?

In a world of longer lives and lower birth rates, the focus is shifting from healthcare as a cost center toward health as an asset with a very high return on investment.

Enhancing global health could generate approximately 288 million additional full-time-equivalent work years by 2050, more than twice the current US labor force (McKinsey Health Institute). As older populations become the primary source of labor force growth in developed markets, this transition requires reimagining longevity – not as a drag on output but as an underutilized source of growth.

Technology is rapidly evolving as a key enabler in this transition. Healthcare is becoming one of the most compelling real-world applications of AI, rapidly powering enhancements in drug discovery, diagnostics, clinical decision-making and operational efficiency.

Far from the clinics and labs, in factories and warehouses, automation and productivity technologies are reducing the intensity of work, enabling older workers to participate in the workforce for longer.

Meanwhile, consumer empowerment and intensifying demand for prevention is driving growth in the USD 6.8 trillion wellbeing economy.

Longevity is also creating opportunities in the financial sector. As individuals live and work longer, demand for life, health and retirement-related insurance is increasing globally, financial solution providers are poised to benefit.

A diagnostic revolution in health

The strategy

Healthy Living goes far beyond traditional healthcare, investing across nutrition, physical wellbeing, prevention, and technological innovation. Recognizing that individuals need clean environments and financial security to thrive, the strategy also invests in companies that promote environmental safety, workforce productivity and life-long financial resilience.

The strategy is exposed to companies that may benefit from the accelerating real-world adoption of artificial intelligence, particularly in healthcare, in life sciences, health services and the workplace, where AI is advancing drug discovery and diagnostics, and human productivity.

Keep your portfolio fit for the future with an investment in Healthy Living.

Footnotes

1How investing in population health fuels global growth | McKinsey
2Treating longevity with healthcare in Asia | McKinsey
3Changes in employment rates of older workers: Pensions at a Glance 2025 | OECD

Thematic investing

Open your portfolio to the power of themes

Let's keep the conversation going

Robeco is an international asset manager offering an extensive range of active investments, from equities to bonds.

Read more

Robeco aims to enable its clients to achieve their financial and sustainability goals by providing superior investment returns and solutions.

Important information: This website is prepared and issued in Australia by Robeco Hong Kong Limited (ARBN 156 512 659) (‘Robeco’) which is exempt from the requirement to hold an Australian financial services licence under the Corporations Act 2001 (Cth) pursuant to ASIC Class Order 03/1103. Robeco is regulated by the Securities and Futures Commission under the laws of Hong Kong and those laws may differ from Australian laws. The information on this web page is provided to you because Robeco reasonably believes that you are a "wholesale client" within the meaning of that term under section 761G(4) of the Corporations Act 2001 (Cth) ("Corporations Act") and not any other class of persons. This information is not an advertisement and is not intended to induce retail clients to acquire Robeco products. Retail clients who are interested in Robeco products should contact their financial adviser.